StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
SaleJul 30, 2026, 05:41 PM

DBV Technologies Sells $50M ADSs via ATM Program to RA Capital

AI Summary

DBV Technologies announced the sale of approximately $50 million in American Depositary Shares (ADSs) through its At-The-Market (ATM) Program to RA Capital Management, L.P. The transaction involves the issuance of 18,288,220 new Ordinary Shares, underlying 3,657,644 ADSs, at a price of $13.67 per ADS. This capital raise is expected to cause a dilution of approximately 5.82% for existing shareholders, with the issuance and delivery anticipated by August 3, 2026.

Key Highlights

  • DBV Technologies to sell approximately $50 million of ADSs.
  • Sale conducted through an At-The-Market (ATM) Program.
  • RA Capital Management, L.P. is the purchaser of the ADSs.
  • 18,288,220 new Ordinary Shares (3,657,644 ADSs) will be issued.
  • Issue price is $13.67 per ADS, representing a 0.15% discount to Euronext Paris closing price.
  • The issuance is expected to result in approximately 5.82% dilution.
  • Issuance and delivery of new Ordinary Shares expected on August 3, 2026.
  • RA Capital will hold 5.82% of the share capital after the ATM Issuance.